Climate & EnergyHealthcareManufacturingLogistics & Supply ChainMobility & TransportationInsuranceInfrastructure & CloudDefense & Space
Mitsui Global Investment (MGI) is the corporate venture capital arm of Mitsui & Co., focusing on early to growth-stage technology companies globally, particularly in areas like AI, IoT, and biotech. Their strategy emphasizes strategic investments that create synergies and new business opportunities for the broader Mitsui Group.
They made 3 investments in the last 12 months. Average disclosed round size is $60.8M (across 10 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Growth
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 LanzaJet | Growth | $135M | Feb 2026 |
 Ellipsis Health | Series A | $45M | Jun 2025 |
 Stately Bio | Seed | $12M | May 2025 |
 Qualis Corporation | Series B | $88M | Mar 2023 |
 Bearing | Seed | $7M | Aug 2022 |
| LanzaJet | Unknown | — | Apr 2021 |
 Yellow Door Energy | Series A | $65M | Jan 2019 |
 Ridecell Inc. | Series B | $60M | Nov 2018 |
 Metromile Inc. | Series D | $103.1M | Sep 2016 |
| KKaminario | Series C | $53M | Dec 2014 |
 Spire | Growth | $40M | — |
Top Co-Investors
Shell3 shared
Khosla Ventures2 shared
Groupe ADP2 shared
Equinor1 shared
Dimension Capital1 shared
Foothill Ventures1 shared
Village Global1 shared
Caffeinated Capital1 shared
BoxOne1 shared
Sequoia Capital1 shared
Tenaya Capital1 shared
Silicon Valley Bank1 shared
Salesforce1 shared
CVS Health1 shared
E121 shared
AME Cloud1 shared
Initialized Capital1 shared
Activate Venture Partners1 shared
LG1 shared
Last updated: 15 April 2026